Dana-Farber/Boston Children's
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fabrizio, Vanessa
NCT05579639: Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

Recruiting
2
419
US
Xylitol, Spiffies Xylitol Wipes, Placebo, Grape-Flavored Wipes
Children's Hospital Medical Center, Cincinnati, National Institute of Dental and Craniofacial Research (NIDCR)
Allogeneic Stem Cell Transplantation
03/26
06/27
REFUEL, NCT05460533: A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

Recruiting
2
33
US
Tisagenlecleucel
Memorial Sloan Kettering Cancer Center, Novartis Pharmaceuticals
B-cell Acute Lymphoblastic Leukemia
07/26
07/26
NCT04544592: UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Recruiting
1/2
50
US
CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
University of Colorado, Denver, National Cancer Institute (NCI)
B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma
06/26
07/26
NCT05642455: SPEARHEAD-3 Pediatric Study

Recruiting
1/2
20
US
Afamitresgene autoleucel
Adaptimmune
Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma, Osteosarcoma
10/26
07/38
NCT06559189: CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Recruiting
1
26
US
CD19x22 CAR T
University of Colorado, Denver
B-cell Acute Lymphoblastic Leukemia
12/28
12/29

Download Options